The shareholders of Norline have entered into a share purchase agreement regarding the sale of the majority in Norline Group to Argos Wityu, an independent European private equity firm. Norline is the largest provider of
Tags :Bär & Karrer
RQM+, the world’s leading MedTech service provider, announced the acquisition of Giotto Compliance from Giotto.ai. Headquartered in Lausanne, Giotto Compliance is a global, all-in-one artificial intelligence (AI) platform designed to increase the efficiency
In line with its expansion strategy the Farner group, a portfolio company of Waterland Private Equity, partnered with the German agencies komm.passion and Kirchhoff Consult to expand its agency alliance “Team Farner”. The komm.
The Swiss Arbitration Centre has appointed Bär & Karrer‘s partner Cinzia Catelli as a new member of their Arbitration Court. The Arbitration Court is an independent body responsible for the administration of arbitration
Bär & Karrer has advised Medbase, a group company of Migros, on the acquisition of the Swiss business of Zur Rose Group, an acknowledged operator in online pharmacy and pharma distribution. The online drug
Pascal Hachem has been appointed as the new co-head of Bär & Karrer‘s Arbitration practice, taking over from Pierre-Yves Gunter. Hachem will co-lead the division alongside Nadja Jaisli. Pascal Hachem’s practice focuses
The Swiss headquartered start-up Mister Loo has completed its Series A financing round over five million USD through the investors Silverhorn SPC and responsibility Investments. The company offers digital public sanitary and healthcare solutions and
Migros-Group invests in the Swiss start-up Revendo, the Swiss market leader in the field of upcycling electronic devices. Sparrow Ventures, Venture Builder and growth capital investor of the Migros Group, is investing in the Swiss
The Farner group, a portfolio company of Waterland Private Equity, partnered with the BlueGlass group to expand its agency alliance “Team Farner”. The Zurich-based BlueGlass group specializes in the fields of digital strategy consulting, search
Helsinn Group, a fully integrated, global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases, has closed a financing agreement with Oberland
